Akademik Veri Yönetim Sistemi
OXFORD MEDICAL CASE REPORTS, cilt.2025, sa.12, 2025 (ESCI, Scopus)
Background Crescentic glomerulonephritis, which is mostly recognized due to lupus nephritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, anti-glomerular basement membrane antibody disease, and immune complex-mediated injury, complicates acute kidney disease (AKD).Case description A 37 year-old male patient with oligo-anuric AKD who developed indications for renal replacement therapy secondary to crescentic complement 3 (C3) glomerulopathy was presented. Endocapillary necrotizing crescentic glomerulonephritis with isolated C3 deposition in the kidney biopsy of our patient was confirmed as complement 3 glomerulopathy (C3G). The patient was successfully treated with oral methylprednisolone and 6 doses of monthly parenteral cyclophosphamide.Conclusion We emphasize the importance of proteinuria evaluation in patients with oligo-anuric AKD even when polyuria phase begins which means that the recovery period of AKD is initiated. Therefore, crescentic C3G should be considered in such patients. Monoclonal gammopathy and genetic factor H defects should be investigated to determine the underlying etiology in C3G patients. Monthly cycles of cyclophosphamide infusion (a total of 6 cycles) are beneficial for these patients.